All Comments by
- Philippe Marambaud on Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease.
- Grace Stutzmann on Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating.
- Ilya Bezprozvanny on A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.
- Grace Stutzmann on A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.
- Ilya Bezprozvanny on Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating.
- Schahram Akbarian on Party of Three: Genes, Environment, and Epigenetics
- Paul Skehel on A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism.
- Paul Skehel on The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors.
- Giuseppa Pennetta on Less VAPid Now: Role for ALS Protein Gets Substance
- Zaven Khachaturian on Sports Concussions, Dementia, and APOE Genotyping: What Can Scientists Tell the Public? What’s Up for Research?
- Terrence Town on Complement: AD Friend or Foe? New Work Tips Balance to Former
- Kumar Sambamurti on Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade.
- Steve Barger on Complement: AD Friend or Foe? New Work Tips Balance to Former
- Jacob Mack on Deactivation Flaws Predict Memory Troubles
- Sébastien S. Hébert on Research Brief: MicroRNA Ties Neuronal Activity to Dendritic Remodeling